| mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
| mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
| mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |